PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Inflammation Research, Queen\'s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh.\', \'Centre for Inflammation Research, Queen\'s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK.\', \'Regional Infectious Disease Unit, NHS Lothian, UK.\', \'Centre for Inflammation Research, Queen\'s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Regional Infectious Disease Unit, NHS Lothian, UK.\', \'Institute of Cancer Sciences, University of Glasgow, UK.\', \'Department of Respiratory Medicine, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board, Glasgow, UK.\', \'Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh.\', \'Latus Therapeutics, Oxford, UK; Department of Pharmacology, University of Oxford, Oxford, UK.\', \'Department of Pharmacology, University of Oxford, Oxford, UK.\', \'Department of Chemistry, University of Oxford, Oxford, UK.\', \'Institute of Pharmaceutical Science, King\'s College London, UK.\', \'Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.\', \'Centre of Excellence for Long-acting Therapeutics, Materials Innovation Factory and Department of Pharmacology and Therapeutics, University of Liverpool, UK.\', \'Centre for Cardiovascular Science, Queen\'s Medical Research Institute, Bioquarter, University of Edinburgh, Edinburgh, UK.\', \'Edinburgh Clinical Trials Unit (ECTU), Usher Institute, University of Edinburgh, Edinburgh, UK.\', \'Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh,; Centre for Cardiovascular Science, Queen\'s Medical Research Institute, Bioquarter, University of Edinburgh, Edinburgh, UK.\', \'Centre for Inflammation Research, Queen\'s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh,. Electronic address: Kev.Dhaliwal@ed.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2352-3964(22)00040-810.1016/j.ebiom.2022.103856
?:hasPublicationType
?:journal
  • EBioMedicine
is ?:pmid of
?:pmid
?:pmid
  • 35152152
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.895
?:rankingScore_hIndex
  • 26
?:title
  • Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35152152>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35152152>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all